Telehealth-Clinical Advocacy Project ((T-CAP))

Texas Christian University

Status: Completed

Conditions: Substance Use

Treatments: Behavioral: Telehealth

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT04911426

5R21DA048232-02

Details and patient eligibility

About

The purpose of this study is to develop a clinical telehealth intervention and test the feasibility of integrating telehealth within a police opioid county diversion program.

Full description

Participants in a police opioid diversion program will receive information about the research opportunity; those interested will be administered informed consent and randomized to either the (1) diversion program treatment as usual condition or (2) the enhanced condition, receiving the telehealth video call intervention with motivational interviewing and substance use treatment appointment reminders during the 12-week intervention. The study design has been modified to provide the enhanced condition with coaching and the T-CAP app to all individuals consented to the study beginning January 1, 2023.

Enrollment: 8 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Individuals interested in joining the study will be

• Enrolled in the A Way Out Opioid Diversion Program (ODP),
• At least 18 years of age,
• Able to speak and understand English,
• Have a history of opioid, alcohol, or other substance use within last 12 months,
• Be willing to provide the research team with access to treatment records,
• Have access to a phone, tablet or computer for the informed consent activity, and
• Have a mailing address to receive a study phone issued to consented participants

Exclusion criteria

Individuals not eligible for the study are

• Not currently enrolled in the A Way Out Opioid Diversion Program on the day of consent,
• Under the age of 18 on the day of consent,
• Unable to speak and understand English,
• Have a history of past opioid, alcohol, or other substance use longer than 12 months ago with no use of opioids in the last 12 months,
• Unwilling to authorize the research team to access treatment records,
• Without access to a phone, tablet or computer to complete the informed consent activity,
• Without a mailing address

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

8 participants in 1 patient group

Treatment plus telehealth

Experimental group

Description:

Individuals will receive telehealth support services, including seven brief motivational interviewing sessions, delivered by a licensed substance use counselor via live interactive video calls during the 12-week intervention.

Treatment:

Behavioral: Telehealth